(Q35363843)

7 August 2017

title

Clofazimine analogs with efficacy against experimental tuberculosis and reduced potential for accumulation (English)

1 reference

7 August 2017

0 references

1 reference

Yu Lu

1

1 reference

7 August 2017

Meiqin Zheng

2

1 reference

7 August 2017

Bin Wang

3

1 reference

7 August 2017

Lei Fu

4

1 reference

7 August 2017

Weijie Zhao

5

1 reference

7 August 2017

Peng Li

6

1 reference

7 August 2017

Jian Xu

7

1 reference

7 August 2017

Hui Zhu

8

1 reference

7 August 2017

Haixia Jin

9

1 reference

7 August 2017

Dali Yin

10

1 reference

7 August 2017

Haihong Huang

11

1 reference

7 August 2017

Anna M Upton

12

1 reference

7 August 2017

Zhenkun Ma

13

1 reference

7 August 2017

language of work or name

English

0 references

publication date

15 August 2011

1 reference

Antimicrobial Agents and Chemotherapy

7 August 2017

published in

1 reference

7 August 2017

volume

55

1 reference

7 August 2017

issue

11

1 reference

7 August 2017

page(s)

5185-5193

1 reference

Reduction of clofazimine by mycobacterial type 2 NADH:quinone oxidoreductase: a pathway for the generation of bactericidal levels of reactive oxygen species

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

A study on the activity of clofazimine with antituberculous drugs against Mycobacterium tuberculosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

Global tuberculosis drug development pipeline: the need and the reality.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

Respiratory ATP synthesis: the new generation of mycobacterial drug targets?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

Clofazimine inhibits human Kv1.3 potassium channel by perturbing calcium oscillation in T lymphocytes

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

A common mechanism of cellular death induced by bactericidal antibiotics

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

Double-blind, randomized, controlled clinical trial of clofazimine compared with chloroquine in patients with systemic lupus erythematosus

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

Replication dynamics of Mycobacterium tuberculosis in chronically infected mice

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

M. tuberculosis persistence, latency, and drug tolerance

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

THE ANTIMYCOBACTERIAL ACTIVITY OF B 663.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

Uptake by reticulo-endothelial cells of the rimino-phenazine B.663(2-P-chloroanilino-5-P-chlorophenyl-3: 5-dihydro-3-isopropyliminophenazine)

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

Miscellaneous treatments: thalidomide, potassium iodide, levamisole, clofazimine, colchicine, and D-penicillamine

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

In vitro investigation of the antimicrobial activities of novel tetramethylpiperidine-substituted phenazines against Mycobacterium tuberculosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

Effective treatment of acute and chronic murine tuberculosis with liposome-encapsulated clofazimine

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

Antimycobacterial activities of riminophenazines

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

Treatment of chronic graft-versus-host disease with clofazimine

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

Antituberculosis activities of clofazimine and its new analogs B4154 and B4157

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

Chemotherapeutic activity of clofazimine and its analogues against Mycobacterium tuberculosis. In vitro, intracellular, and in vivo studies

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

A review of side-effects experienced by patients taking clofazimine

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

The antileprosy agent B.663 (Clofazimine) and the reticuloendothelial system

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

Tissue concentrations of clofazimine (B663) in man.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

Clofazimine analogues active against a clofazimine-resistant organism.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

Apparent involvement of phospholipase A2, but not protein kinase C, in the pro-oxidative interactions of clofazimine with human phagocytes

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

Clofazimine-mediated enhancement of reactive oxidant production by human phagocytes as a possible therapeutic mechanism

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

Clofazimine: a review of its use in leprosy and Mycobacterium avium complex infection.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

Clofazimine crystals in alveolar macrophages from a patient with the acquired immunodeficiency syndrome

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

Identification of crystals of the rimino-phenazine compound B663 (lamprene: Clofazimine) in mouse spleen macrophages by thin layer chromatography and mass spectrum analysis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

Tissue distribution and deposition of clofazimine in mice following oral administration of isoniazid

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

Activities of clofazimine against Mycobacterium tuberculosis in vitro and in vivo

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

Antimicrobial activities of seven novel tetramethylpiperidine-substituted phenazines against multiple-drug-resistant Gram-positive bacteria.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

Treatment of Leprosy with a Phenazine Derivate (B 663 or G 30 320) - Clofazimine

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195009

Effects of clofazimine analogues and tumor necrosis factor-alpha individually and in combination on human polymorphonuclear leukocyte functions in vitro

26 September 2018

1 reference

12 December 2020

Skin pigmentation from clofazimine therapy in leprosy patients: a reappraisal

1 reference

12 December 2020

Determination of serum and tissue levels of phenazines including clofazimine

1 reference

12 December 2020

A study of skin pigmentation by clofazimine

1 reference

12 December 2020

Tissue distribution and deposition of clofazimine in rat following subchronic treatment with or without rifampicin

1 reference

12 December 2020

Spaced clofazimine therapy of lepromatous leprosy

1 reference

12 December 2020

Tissue levels of clofazimine in a case of leprosy

1 reference

12 December 2020

A New Series of Phenazines (Rimino-Compounds) With High Antituberculosis Activity

1 reference

12 December 2020

Pharmacologic Studies of Clofazimine *

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.00699-11

1 reference

7 August 2017

1 reference

7 August 2017

1 reference